The FDA has approved required updates to the labeling of Pfizer’s Comirnaty and Moderna’s Spikevax COVID-19 vaccines to include revised warnings about the risk of myocarditis and pericarditis ...

Discover the latest FDA warning updates for COVID vaccines including increased health risks and new restrictions for healthy adults.

While US exceptionalism may have lost some of its shine, it is worth remembering that the US stock market remains home to ...

The Food and Drug Administration has approved Moderna’s new COVID-19 vaccine, mNEXSPIKE, The approval was announced Saturday by Moderna, which recommends mNEXSPIKE for adults aged 65 and older and ...

Moderna's new flu vaccine, based on the same mRNA technology used in its COVID-19 shot, showed promising results in a major ...

An mRNA-based seasonal flu vaccine from Moderna was 27 percent more effective at preventing influenza infections than a ...

Dr. Jeffrey Kopin, Chief Medical Officer for Northwestern Medicine Lake Forest Hospital, joins John Williams to talk about ...

Moderna, Inc. (MRNA)’s share was trading at $26.67 as of 13th June. MRNA’s trailing P/E was 7.06 according to Yahoo Finance. Moderna’s stock has fallen nearly 94% from its pandemic-era highs ...

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

Moderna convinced a U.S. appeals court on Wednesday to uphold a ruling that undercut patent infringement claims by biotech company Alnylam Pharmaceuticals over Moderna's blockbuster COVID-19 ...

Moderna MRNA announced the FDA approval for mRNA-1283, its next-generation refrigerator-stable COVID-19 vaccine, though for a label narrower than initially targeted. The vaccine will be marketed ...